Any CR prior to results would be a failure of this position.
A partnership imo is ultimately what we need. More dilution of shares through a CR is a horrow show.
Not seeing any management buy shares on market, just happy to take the freebies I guess - why pay for them...
- Forums
- ASX - By Stock
- per-chart
Any CR prior to results would be a failure of this position. A...
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
-0.002(2.35%) |
Mkt cap ! $86.05M |
Open | High | Low | Value | Volume |
8.5¢ | 8.6¢ | 8.3¢ | $72.87K | 861.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 204125 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 97200 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 204125 | 0.082 |
3 | 287000 | 0.081 |
10 | 935186 | 0.080 |
6 | 413817 | 0.079 |
6 | 689399 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 97200 | 5 |
0.085 | 280000 | 3 |
0.086 | 96543 | 1 |
0.088 | 27962 | 1 |
0.089 | 200000 | 1 |
Last trade - 15.50pm 13/11/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online